Chai Discovery

Chai Discovery develops AI models for designing molecules, including Chai-2 for de novo antibody and miniprotein design against a chosen target. It gives commercial organizations access on request, plans limited non-commercial use, and lists a Novartis collaboration and a Pfizer license agreement.

StageLate-stage
Founded2024
HeadquartersSan Francisco, USA
StatusPrivate
chaidiscovery.com

Product

Selected offerings — the AI products recorded here, not the vendor's full catalogue.

Closest alternatives 2

Similar products 11

How this list is ranked ↗

Recursion PharmaceuticalsPublicChai Discovery platform and Recursion OS both list drug discovery; both also serve buyers who need to find drug candidates faster; smaller scale (public).1 of 1 capabilityShared product typeSmaller scaleCompareInsilico MedicinePublicChai Discovery platform and Pharma.AI both list drug discovery; both also serve buyers who need to find drug candidates faster; similar scale (public).1 of 1 capabilityShared product typeCompareCradleLate-stageChai Discovery platform and Cradle both list drug discovery; both also serve buyers who need to find drug candidates faster; Cradle's scale not recorded.1 of 1 capabilityShared product typeCompareOrigin BioUndisclosedChai Discovery platform and Origin Bio data engine and Axis both list drug discovery; both also serve buyers who need to find drug candidates faster; Origin Bio's scale not recorded; ships data service rather than the same layer.1 of 1 capabilityDifferent layerCompareReflector BioUndisclosedChai Discovery platform and Reflector phenotypic screening both list drug discovery; both also serve buyers who need to find drug candidates faster; Reflector Bio's scale not recorded; ships application rather than the same layer.1 of 1 capabilityDifferent layerCompareOwkinLate-stageChai Discovery platform and BiomarkerPlus both list drug discovery; Owkin's scale not recorded; ships AI agent and data service rather than the same layer.1 of 1 capabilityDifferent layerCompareLunitPublicChai Discovery platform and Lunit SCOPE both list drug discovery; both also serve buyers who need to find drug candidates faster; Lunit's scale not recorded; ships application rather than the same layer.1 of 1 capabilityDifferent layerCompareGoogle DeepMindAcquiredChai Discovery platform and AlphaFold Server both list drug discovery; Google DeepMind is acquired, with no independent scale; ships application and model API rather than the same layer.1 of 1 capabilityDifferent layerCompareTempus AIPublicChai Discovery platform and Tempus Lens both list drug discovery; larger scale (public).1 of 1 capabilityShared product typeLarger scaleCompareHuawei CloudUndisclosedChai Discovery platform and EIHealth both list drug discovery; both also serve buyers who need to find drug candidates faster; Huawei Cloud's scale not comparable: only a revenue estimate, no market cap or valuation.1 of 1 capabilityShared product typeCompareNVIDIAPublicChai Discovery platform and NVIDIA BioNeMo both list drug discovery; larger scale (public).1 of 1 capabilityShared product typeLarger scaleCompare

Closest alternatives are pairs a vendor page itself compares. Similar products are matched from what each product does; nothing in that group is asserted as a rivalry.

Sources

Total funding

News reporting · 14 Jul 2026

Chai brews up $400M series C to fuel AI molecule models used by Lilly, Novartis and Pfizer, Fierce Biotech, July 14, 2026. Read via stockanalysis.com's citation for this figure on 2026-08-27.

Stage, from valuation

Press release · 14 Jul 2026

Series C: Announcing our $400M fundraise, Chai Discovery, 2026-07-14. post-money valuation of the round dated 2026-07-14. Read via stockanalysis.com's citation for this figure on 2026-08-27.

Founded

Press release · 11 Sep 2026

"Chai was founded in 2024 by Joshua Meier..., Jack Dent..., and AI researchers Matthew McPartlon and Jacques Boitreaud."

Open Chai Discovery in the directory

Something wrong here? Send a correction — quote this company id: chai-discovery.